Your search returned 2 results.

Results
	1.	Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin. [electronic resource] by Kapitza, C Forst, T Coester, H-V Poitiers, F Ruus, P Hincelin-Méry, A Producer: 20140110 In: Diabetes, obesity & metabolism vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. [electronic resource] by Rup, B Pallardy, M Sikkema, D Albert, T Allez, M Broet, P Carini, C Creeke, P Davidson, J De Vries, N Finco, D Fogdell-Hahn, A Havrdova, E Hincelin-Mery, A C Holland, M H Jensen, P E Jury, E C Kirby, H Kramer, D Lacroix-Desmazes, S Legrand, J Maggi, E Maillère, B Mariette, X Mauri, C Mikol, V Mulleman, D Oldenburg, J Paintaud, G R Pedersen, C Ruperto, N Seitz, R Spindeldreher, S Deisenhammer, F Producer: 20151117 In: Clinical and experimental immunology vol. 181 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search